Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758081 · ClinicalTrials.gov registry record · NA
Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)
A NA study of Infections and Human Cathelicidin Antimicrobial Peptide (hCAP-18), sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 25,874
- Enrollment target
- 1
- Study location
NCT01758081: Active NA study of Infections and Human Cathelicidin Antimicrobial Peptide (hCAP-18), sponsored by Brigham and Women's Hospital.
NCT01758081 is a NA study of Infections and Human Cathelicidin Antimicrobial Peptide (hCAP-18) that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,874 participants, above the 2,412-participant average among 26 other Infections trials with a reported enrollment target (973% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01758081, a NA study of Infections and Human Cathelicidin Antimicrobial Peptide (hCAP-18), is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25,874 participants
- Enrollment target
- 1
- Study location
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or omega-3 fatty acids affect risk of infection and plasma hCAP18 levels.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DRUG omega-3 fatty acids (fish oil)
- DIETARY_SUPPLEMENT fish oil placebo
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,874 participants |
| Start Date | 2010-07 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT01758081 still lists
NCT01758081 is an interventional study that assigns participants to a tested intervention. Its 25,874 participants enrollment target places it among the larger protocols in the corpus, above the 2,412-participant average among 26 other Infections trials with a reported enrollment target (973% higher).
The record links to 2 conditions, with Infections appearing as the primary indexed condition, and to 4 interventions - of which vitamin D3 is the first listed.
NCT01758081 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01758081 about?
NCT01758081 is a clinical study titled "Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart dis...
What is the current status of trial NCT01758081?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,874 participants. The study started on 2010-07. Estimated completion is 2026-12.
What conditions does trial NCT01758081 study?
This clinical trial studies the following conditions: Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18).
What interventions are being tested in trial NCT01758081?
The interventions under investigation include: vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), omega-3 fatty acids (fish oil) (DRUG), fish oil placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01758081?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01758081 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01758081's enrollment target sits among peer trials
25,874 2nd of 26 the highest of 26 other Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
RECRUITING · NA
-
Augmented Reality For MRI-Guided Interventions
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
RECRUITING · NA
-
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
RECRUITING · NA
-
Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia